Intensive Studies for Recertification: Compounded Sterile Preparations (Cert # L209323)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 07/29/2020
Content Release Date: 08/26/2020
Expiration Date: 08/24/2021
Activity Type: Application-based
CE Credits: 4.50 (BPS and ACPE)
Activity Fee: $100 (ASHP member); $150 (non-member) 

Accreditation for Pharmacists

 ASHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These activities were part of the 2019 ASHP Midyear Clinical Meeting and Exhibition and 2020 ASHP Summer Meetings and Exhibition. Learners who previously claimed ACPE credit for these activities should not claim ACPE credit again.

Target Audience

These recertification activities are intended for board-certified pharmacists seeking to update their knowledge and skills in:

  • Safety in smart pumps
  • 503B outsourcing facilities
  • Corrective Action & Preventive Actions (CAPA)
  • Microbial evaluation

Activity Overview

The Intensive Study Package is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues in compounding sterile preparations.

These activities are part of the ASHP professional development program for BCSCP recertification approved by the BPS.

Recertification Credit*

Board-certified pharmacists are eligible to receive up to 4.50 hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

 

Learning Module

ACPE Number

Credit Hours

*Assessment Pass Point

Microbial Evaluation for Sterile Compounders

0204-0000-20-122-H07-P

1.00

81%

CAPA:  Corrective Action Preventive Action

0204-0000-20-126-H07-P

1.00

76%

Evaluation of 503B Outsourcing Facilities – Going Beyond the Checklist

0204-0000-20-127-H07-P

1.00

72%

Strategies to Maximize the Safety of Your Smart Pumps

0204-0000-19-269-H04-P

1.50

80%

 

Learning Objectives

Microbial Evaluation for Sterile Compounders

0204-0000-20-122-H07-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Apply the standards related to sterile preparations (e.g., United States Pharmacopeia, National Institute for Occupational Safety and Health) and to environmental monitoring.
  • Explain the principles of viable and non-viable particle generation and control.
  • Design practices to support appropriate environmental monitoring
CAPA:  Corrective Action Preventive Action

0204-0000-20-126-H07-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Define the concept and key elements of corrective action and preventive action (CAPA)
  • Differentiate root cause analysis methods and techniques
  • Identify appropriate corrective and preventive actions of presented examples
  • Design CAPA documentation with appropriate data elements
Evaluation of 503B Outsourcing Facilities – Going Beyond the Checklist

0204-0000-20-127-H07-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Differentiate USP standards from cGMP
  • Apply citations in FDA 483 to current practice
  • Design a plan to evaluate an outsourcing facility
Strategies to Maximize the Safety of Your Smart Pumps

0204-0000-19-269-H04-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Analyze strategies to maximize smart pump safety
  • Devise methods for evaluating smart pump data
  • Develop an action plan for establishing interoperability between smart pumps and the electronic health record (EHR)

Planners, Presenters, and Reviewers 

Cindy Chan, Pharm.D.
Pharmacy Operations Manager
Providence Infusion and Pharmacy Services
Tukwila, Washington
Clay Daniels, Pharm.D., Ph.D., BCPPS
Clinical Pharmacist, Medication Safety & Informatics
St. Jude Children’s Research Hospital
Memphis, Tennessee
Kevin N. Hansen, Pharm.D., M.S., BCPS, BCSCP
Assistant Director, Residency Program Director
Moses H. Cone Memorial Hospital/Cone Health
Browns Summit, North Carolina
Ken Jozefczyk, M.S., R.Ph., FASHP
Director, Centralized Pharmacy Services
BayCare Health System
Tampa, Florida
Jennifer Robertson, Pharm.D., BCPS
Medication Outcomes & Safety Officer
St. Jude Children’s Research Hospital
Memphis, Tennessee

Jeff Arquiette, B.S., BCSCP
Nicholas Baker, Pharm.D., M.P.H., BCPS, BCSCP
Paul Baker, Pharm.D., BCSCP
Mark Barricklow, R.Ph., BSCP
Jasmin Brown, Pharm.D., BCSCP
Cody Burger, Pharm.D., BCSCP
Kathy Chang, Pharm.D., BCSCP
Marcos Contreras, Pharm.D., BCNP, BCSCP
Heather DeSanto, Pharm.D., BCSCP
Eric Ferro, Pharm.D., BCPS, BCSCP
Christopher Flores, Pharm.D., BCPS, BCSCP
Varsha Gaitonde, Pharm.D., Ph.D., BCPS, BCSCP
Lara Ann Greenhalgh, Pharm.D., BCSCP
David Halterman, Pharm.D, BCSCP
Alesia Hanson, R.Ph., BSCP
Amanda Harding, Pharm.D., BCSCP
Kathleen Kane, Pharm.D., BCSCP
Lynda Kiliany, B.S.Pharm., Pharm.D., BCSCP
Kylian Kirkham, Pharm.D., BCSCP
Susan Kleppin, R.Ph., FASHP, BCSCP
Iris Kuhn, Pharm.D., BCSCP
Brandon Kuperinsky, Pharm.D., BCSCP
Kenneth Lazenby, Pharm.D., BCSCP
Valerie Lindeborg, Pharm.D., BCOP, BCSCP
Jennifer Lindgren, Pharm.D., BCSCP, RPSGT
Robert Macarthur, Pharm.D., M.S., BCSCP
John Mattern, BSc.Pharm, Pharm.D., BCSCP
Aura Matyjas, Pharm.D., BCSCP
Kimberly Mccall, Pharm.D., BCSCP
Mary McGarry, B.S., Pharm.D., BCPS
Conor McGladrigan, Pharm.D., JD, BCSCP
Ngoc Nguyen, Pharm.D., BCSCP
Carrie Reedy, R.Ph., BSCP
Catherine Richwine, B.S., BCSCP
Joanna Robinson, Pharm.D., M.S., BCSCP
Beman Saleeb, Pharm.D., BCSCP, CPh
Leigh Samuel, Pharm.D.,BCSCP
Brittany Singleton, B.A., Pharm.D., BCPS, BCSCP
Chad Smith, Pharm.D., M.B.A., BCPS, BCSCP
Alison Smith, Pharm.D., BCSCP
Kathryn Stone, Pharm.D., BCSCP
Lance Thompson, Pharm.D., BCSCP
Matthew Tobin, Pharm.D., M.B.A., BCSCP
Ulfat Usta, Pharm.D., BCPS, BCNS, BCCSP
Brian Verlizzo, Pharm.D., MHA, BCSCP
Robert Vitale, B.S., Pharm.D., BCSCP
Wendy Waldman, R.Ph., BCSCP, CPPS

.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

All planners, presenters, reviewers, ASHP staff, and others with an opportunity to control content report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.